Business Advancement Center for Health

BACH highlights the value of collaboration among stakeholders and will host roundtables and consortia with industry and community partners, conferences, multi-sector forums, and interdisciplinary student competitions. Past events are also available to watch.

Participatory research projects will engage the community and industry, along with faculty and students. This ecosystem will complement Carlson School coursework, expose students to state-of-the-art thinking, and engage faculty in innovative real-world health sector solutions.

Bridging the intersections of community, industry, and academia, BACH aligns sectors of the health economy to co-create innovative solutions to drive marketplace implementation. Learn more about how your gifts help to support BACH's research and activities for industry professionals and students here. 

Four BACH-affiliated researchers have co-authored a pivotal paper titled "Merchants of Death: The Effect of Credit Supply Shocks on Hospital Outcomes," which will be published in the November issue of the American Economic Review—the top-ranked journal in economics. This research offers crucial insights into how credit market frictions can have unintended, far-reaching consequences on health outcomes, exemplifying BACH’s commitment to advancing critical, cross-disciplinary scholarship at the intersection of health and economics.

On October 15, 2024, the third annual Health Sector Leaders Consortium was held, bringing together over 90 healthcare leaders, professionals, and innovators. This year, the event featured four influential speakers who highlighted critical issues such as hybrid care models, the social impact of healthcare technology, hospital capacity management, and digital health solutions.

The Health Sector Leaders Consortium is a unique opportunity for leaders from various sectors to share their perspectives on the challenges, innovations, and opportunities they encounter in their efforts to advance value and equity in health. 

A new, nearly $1.6 million grant is fueling research at the Carlson School of Management, out of the Carlson School’s Business Advancement Center for Health (BACH), to better understand how the rapid flow of information during the COVID-19 pandemic impacted medication treatments for the disease.